The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R)-2-(6-((2S)-4-((6-Amino-3-pyridinyl)-sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)-3-pyridinyl)-3,3,3-trifluoro-1,2-propanediol ID: ALA3238314
PubChem CID: 89762388
Max Phase: Preclinical
Molecular Formula: C20H22F3N5O4S
Molecular Weight: 485.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC#C[C@H]1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc([C@@](O)(CO)C(F)(F)F)cn1
Standard InChI: InChI=1S/C20H22F3N5O4S/c1-2-3-15-12-27(33(31,32)16-5-6-17(24)25-11-16)8-9-28(15)18-7-4-14(10-26-18)19(30,13-29)20(21,22)23/h4-7,10-11,15,29-30H,8-9,12-13H2,1H3,(H2,24,25)/t15-,19-/m0/s1
Standard InChI Key: XZAJRLOTZNWGPU-KXBFYZLASA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
7.8292 -21.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8600 -25.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1149 -22.0424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0330 -24.4975 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4034 -24.9085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8616 -27.7920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9855 -24.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2785 -24.4989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5397 -22.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2498 -21.6329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8537 -24.5017 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.8288 -20.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6934 -22.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3999 -21.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1471 -26.5624 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4037 -23.2754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4449 -23.7893 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5626 -23.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8206 -19.9891 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1081 -25.3142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1140 -20.4007 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5742 -26.5619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5389 -20.4000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.5373 -21.2141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5667 -24.0951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6934 -24.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6927 -22.0431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8618 -26.9711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1482 -25.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5713 -25.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1138 -22.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2759 -22.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9873 -23.2707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7 33 1 0
17 11 2 0
3 1 1 0
28 6 1 0
12 21 1 0
7 26 1 1
33 13 1 0
13 16 2 0
28 22 2 0
2 29 1 0
27 13 1 0
1 12 1 6
12 23 1 0
33 32 1 0
1 9 1 0
12 19 1 0
14 27 2 0
2 11 1 0
26 5 3 0
31 3 2 0
15 28 1 0
11 25 1 0
8 7 1 0
11 4 2 0
16 31 1 0
9 10 1 0
30 2 2 0
1 24 1 0
5 20 1 0
32 18 1 0
3 14 1 0
25 18 1 0
29 15 2 0
25 8 1 0
22 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.49Molecular Weight (Monoisotopic): 485.1345AlogP: 0.70#Rotatable Bonds: 5Polar Surface Area: 132.88Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.80CX Basic pKa: 5.67CX LogP: 1.29CX LogD: 1.29Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -1.08
References 1. Nishimura N, Norman MH, Liu L, Yang KC, Ashton KS, Bartberger MD, Chmait S, Chen J, Cupples R, Fotsch C, Helmering J, Jordan SR, Kunz RK, Pennington LD, Poon SF, Siegmund A, Sivits G, Lloyd DJ, Hale C, St Jean DJ.. (2014) Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine series., 57 (7): [PMID:24611879 ] [10.1021/jm5000497 ]